» Articles » PMID: 12355212

Overexpression of Cyclin E Protein is Closely Related to the Mutator Phenotype of Colorectal Carcinoma

Overview
Date 2002 Oct 2
PMID 12355212
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aims: A subset of colorectal carcinomas are due to a deficiency in the DNA mismatch repair system. The molecular mechanisms of tumorigenesis in these tumors is not yet well understood. Deregulation of the cell cycle, specifically of the G(1) and S phases, is a hallmark of human cancers. Transition from the G(1) to the S phase is accelerated by increased cyclin E protein expression, and recent studies suggest that overexpression of cyclin E leads to chromosomal instability. The overexpression of cyclin E in a variety of human cancers, for example in colorectal, gastric, lung, breast, and kidney cancer, provides evidence that cyclin E plays a pivotal role in the cell cycle and replication. We examined whether the overexpression of cyclin E is related to the status of the mismatch repair system in colorectal carcinomas.

Patients And Methods: Frozen tumor samples and adjacent normal colon mucosa obtained from 100 patients were subjected to microsatellite analysis, RT-PCR, western blot analysis and immunohistochemistry.

Results: High microsatellite instability was detected in 13 tumors, and in 10 of these (77%) cyclin E protein was overexpressed at least twofold compared to normal mucosa. In contrast, only 28 of the remaining 87 microsatellite stable tumors (32%) overexpressed cyclin E. Lower molecular weight cyclin E proteins were present in 7 of 87 microsatellite stable carcinoma (8%), compared to 7 cases exhibiting lower molecular weight isoforms of 13 MSI carcinoma (54%).

Conclusion: Increased cyclin E protein expression and the appearance of lower molecular weight cyclin E proteins were significantly associated with MSI in colorectal tumors. The data indicate that increased and/or aberrant expression of cyclin E protein might contribute to the mutator phenotype of colorectal cancer.

Citing Articles

Does cyclin E and p57 expression have prognostic and survival value in colorectal adenocarcinoma?.

Ozgur T, Sumbul A, Yaldiz M, Temiz M, Akdag A Int J Clin Exp Pathol. 2020; 11(8):3867-3875.

PMID: 31949774 PMC: 6962821.


Molecular crosstalk between cancer and neurodegenerative diseases.

Seo J, Park M Cell Mol Life Sci. 2019; 77(14):2659-2680.

PMID: 31884567 PMC: 7326806. DOI: 10.1007/s00018-019-03428-3.


Analysis of cyclin E co-expression genes reveals nuclear transcription factor Y subunit alpha is an oncogene in gastric cancer.

Bie L, Li D, Mu Y, Wang S, Chen B, Lyu H Chronic Dis Transl Med. 2019; 5(1):44-52.

PMID: 30993263 PMC: 6449734. DOI: 10.1016/j.cdtm.2018.07.003.


Low-Molecular-Weight Cyclin E in Human Cancer: Cellular Consequences and Opportunities for Targeted Therapies.

Caruso J, Duong M, Carey J, Hunt K, Keyomarsi K Cancer Res. 2018; 78(19):5481-5491.

PMID: 30194068 PMC: 6168358. DOI: 10.1158/0008-5472.CAN-18-1235.


Expression of cyclin E in stage III colorectal carcinoma.

Rath-Wolfson L, Bergman M, Ori Y, Goldman A, Ram E, Koren R Oncol Lett. 2012; 5(1):145-148.

PMID: 23255910 PMC: 3525508. DOI: 10.3892/ol.2012.955.